Hinge Health Inc. Class A Common Stock vs Microchip Technology Inc. — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while Microchip Technology Inc. trades at $70.28 (market cap $38.69B). The key difference: Microchip Technology Inc. is far larger — about 4.6× Hinge Health Inc. Class A Common Stock's market cap, and Microchip Technology Inc. pays a 2.55% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Microchip Technology Inc. for 63 Days on average.
| HNGE | MCHP | |
|---|---|---|
Market Cap | $8.47B | $38.69B |
Volume | 1,624,526 | 14,380,005 |
Sector | Health | Technology |
52-Week High | $105.14 | $102.97 |
52-Week Low | $31.17 | $49.02 |
Typical Hold Time | 0 Days | 63 Days |
Enterprise Value | $8.09B | $43.82B |
Dividend Yield | — | 2.55% |
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Microchip Technology (MCHP) trades at $74.16, up 0.45% on the day, with a bearish technical signal but strong analyst consensus. The company has beaten EPS estimates for the last three quarters, though 2025 saw a net loss amid revenue contraction. Recent news highlights expansion in Ethernet and 48V power portfolios, along with the completed acquisition of Hailo, targeting growth in automotive, industrial, and AI infrastructure markets.
The outlook is mixed: robust buy-side analyst support and strategic positioning in high-growth sectors offer upside potential, but high valuation multiples, significant debt, and recent profitability challenges present risks. The consensus price target of $110.50 implies substantial appreciation, contingent on successful execution and market demand recovery.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →